Infervision’s AI Solution Cleared for Lung Segmentation

Infervision has received 510(k) clearance from the FDA for its InferRead Lung CT.AI application that analyzes CT scans to help radiologists diagnose lung diseases.

The artificial intelligence-based algorithm automatically identifies and labels lung nodules of different types to support radiologists in their review of chest scans.

The algorithm can find hard-to-see nodules, so it is a useful new tool for cancer screening programs, the company said. The application has previously earned a CE Mark certification.